drugset / Trial / NCT01687049

Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance

NCT01687049

Phase 2 Unknown 60 enrolled Dr. Laurence Klotz
NaSingle-groupOpen-labelTreatment

Summary

Agents that inhibit cholesterol synthesis are being investigated in cancers dependent upon cholesterogenesis. Red yeast rice (RYR), is a reddish-purple fermented rice, containing statins which are known to inhibit cholesterol synthesis. Laboratory studies have also shown that RYR has direct effects on androgen dependent and androgen independent prostate cancer cells, inhibiting their growth. It is thought that RYR may have clinical benefit in those subjects with localized prostate cancer who have chosen to be managed by active surveillance.

Timeline

Start
2013-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject red yeast rice Traditional medicine (herbal / TCM)

Indications